Sarepta Therapeutics Inc (SRPT)
110.50
-0.36
(-0.32%)
USD |
NASDAQ |
Nov 21, 16:00
111.10
+0.60
(+0.54%)
After-Hours: 20:00
Sarepta Therapeutics Price to Book Value: 8.644 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 8.644 |
| November 20, 2024 | 8.672 |
| November 19, 2024 | 8.340 |
| November 18, 2024 | 8.188 |
| November 15, 2024 | 8.178 |
| November 14, 2024 | 8.535 |
| November 13, 2024 | 8.799 |
| November 12, 2024 | 8.943 |
| November 11, 2024 | 9.218 |
| November 08, 2024 | 9.513 |
| November 07, 2024 | 9.42 |
| November 06, 2024 | 10.01 |
| November 05, 2024 | 9.779 |
| November 04, 2024 | 9.627 |
| November 01, 2024 | 9.644 |
| October 31, 2024 | 9.854 |
| October 30, 2024 | 9.993 |
| October 29, 2024 | 10.18 |
| October 28, 2024 | 10.19 |
| October 25, 2024 | 10.26 |
| October 24, 2024 | 10.32 |
| October 23, 2024 | 10.16 |
| October 22, 2024 | 10.04 |
| October 21, 2024 | 9.956 |
| October 18, 2024 | 9.938 |
| Date | Value |
|---|---|
| October 17, 2024 | 9.717 |
| October 16, 2024 | 9.848 |
| October 15, 2024 | 9.676 |
| October 14, 2024 | 9.726 |
| October 11, 2024 | 9.737 |
| October 10, 2024 | 9.573 |
| October 09, 2024 | 9.227 |
| October 08, 2024 | 9.363 |
| October 07, 2024 | 9.212 |
| October 04, 2024 | 9.416 |
| October 03, 2024 | 9.288 |
| October 02, 2024 | 9.582 |
| October 01, 2024 | 9.567 |
| September 30, 2024 | 9.767 |
| September 27, 2024 | 11.03 |
| September 26, 2024 | 11.05 |
| September 25, 2024 | 11.03 |
| September 24, 2024 | 11.11 |
| September 23, 2024 | 11.05 |
| September 20, 2024 | 11.26 |
| September 19, 2024 | 11.25 |
| September 18, 2024 | 11.07 |
| September 17, 2024 | 11.13 |
| September 16, 2024 | 11.01 |
| September 13, 2024 | 11.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
5.929
Minimum
Jan 19 2022
37.12
Maximum
Mar 07 2023
13.22
Average
12.14
Median
Price to Book Value Benchmarks
| Catalyst Pharmaceuticals Inc | 3.811 |
| Madrigal Pharmaceuticals Inc | 9.240 |
| Vertex Pharmaceuticals Inc | 7.420 |
| Viking Therapeutics Inc | 6.312 |
| Regenxbio Inc | 1.509 |
Price to Book Value Related Metrics
| PE Ratio | 71.75 |
| PS Ratio | 6.778 |
| Price | 110.50 |
| Earnings Yield | 1.39% |
| Market Cap | 10.55B |
| Operating PE Ratio | 137.22 |
| Normalized PE Ratio | 67.73 |